ApcinteX Ltd
http://apcintex.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ApcinteX Ltd
Centessa ‘Creates Pharma Pipeline Overnight’ Using Novel R&D Approach
With $250m in series A funding, Cambridge, MA-based Centessa is looking to upend traditional biopharma R&D models. The new company was created through the merger of 10 private biotechs, which will sit under the Centessa umbrella as subsidiaries.
Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
ApcinteX Ltd
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice